Titel	Veröffentlichungsdatum	Sprache	Zitate
Exploring the Comparability Between EQ-5D and the EQ Health and Wellbeing in the General Australian Population	2024/04/01	English
Editorial Board	2023/08/01	English
The Feasibility and Validity of Preference-Based Quality of Life Measures With Informal Carers: A Think-Aloud Study	2023/11/01	English
Instructions for Authors	2023/08/01	English
Table of Contents	2023/08/01	English
Copyright/Subscription	2023/08/01	English
How Do Patients With Type 2 Diabetes Mellitus Value the Importance of Outcomes? An Overview of Reviews	2023/12/01	English
Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory follicular lymphoma in the United States	2024/04/01	English
The Long Coronavirus Disease (COVID) Symptom and Severity Score: Development, Validation, and Application	2024/04/01	English
Validating health economic models with the Probabilistic Analysis Check dashBOARD (PACBOARD)	2024/04/01	English
Economic Evaluations of CAR-T Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review	2024/04/01	English
Subjective well-being population norms and inequalities in Hungary: a large cross-sectional, internet-based survey	2024/04/01	English
Health Fluctuations in Dementia and its Impact on the Assessment of Health-related Quality of Life using the EQ-5D-5L	2024/04/01	English
Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015–2019	2024/04/01	English
Decision Makers Should Avoid the Health Years in Total (HYT) Approach: A Response to Dr Basu	2024/04/01	English
The Inflation Reduction Act: An Opportunity to Accelerate Confidence in US Real-World Evidence.	2024/04/01	English
J1: IDENTIFYING INITIAL DIAGNOSIS IN DATABASE RESEARCH	1999/01/01	English
DISCLOSURE INFORMATION	1999/05/01	English
PHARMACOECONOMIC EVALUATION OF FILGRASTIM (r-metHuG-CSF) TREATMENT IN AUTOLOGOUS BONE MARROW TRANSPLANTATION	1999/09/01
Modeling for policy-makers the expected benefits of prevention	1999/05/01
PHP1: INTEGRATING HEALTH ECONOMICS INTO THE PRODUCT DECISION- MAKING PROCESS: LESSONS LEARNED FROM DECISION-MAKERS	2001/09/01	English
Letter to the Editor	2002/01/01	English
THE EUROPEAN REGULATORY ISSUES ON QUALITY OF LIFE ASSESSMENT (ERIQA) PROJECT	1999/09/01
PGS7: ISSUES IN USING CONJOINT ANALYSIS TO VALUE HEALTH CARE WITHIN CLINICAL STUDIES	2000/09/01	English
NR2: QUALITY OF LIFE AFTER SUBARACHNOID HEMORRHAGE IN RELATION TO RISK ESTIMATION BEFORE SURGERY	2000/09/01	English
Outcomes Research in the Health-Care System: Driven by Results	2002/01/01	English
Development and Valuation of a Preference-Weighted Measure in Age-Related Macular Degeneration From the Vision Impairment in Low Luminance Questionnaire—A MACUSTAR Report	2024/02/01	English
Acceptability of Using Real-World Data to Estimate Relative Treatment Effects in Health Technology Assessments: Barriers and Future Steps	2024/02/01	English
An Intersectional Approach to Quantifying the Impact of Geographic Remoteness and Health Disparities on Quality-Adjusted Life Expectancy: Application to Australia	2023/12/01	English
An Updated Review of Food and Drug Administration Warning and Untitled Letters for Clinical Outcome Assessment Claims Between 2013 and 2021	2023/12/01	English